Why AbbVie Stock Slumped Today
High-flying pharmaceutical company (NYSE: ABBV) has seen its stock rise in many recent sessions. Yet Friday's wasn't one of them, as the company's shares took a nearly 3% loss on the back of a second-quarter earnings report that investors found uninspiring.
AbbVie unveiled that quarter's figures before market open. Its revenue came in at just under $17 billion for the period, which was more than 10% higher year over year. It also managed to boost its net income not under generally accepted accounting principles (non-GAAP, or adjusted) by 23% to almost $6.5 billion, or $3.65 per share.
Image source: Getty Images.
Source Fool.com
AbbVie Inc. Aktie
213,10 €
0,52 %
Die AbbVie Inc. Aktie ist ein Favorit: Nur Buy-Einschätzungen, keine Sell-Einschätzungen.
Ein leicht positives Potenzial wird für AbbVie Inc. mit einem Kursziel von 228 € im Vergleich zu 213.1 € gesehen.
